The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC).
 
Aarti Bhatia
Honoraria - Coherus Biosciences; Merck Serono; Peerview
Consulting or Advisory Role - daiichi sankyo
Research Funding - Boehringer Ingelheim; Genentech
 
Wei Wei
No Relationships to Disclose
 
Michael Chiorazzi
No Relationships to Disclose
 
Hari Deshpande
Employment - Yale Cancer Center
Honoraria - AADi; Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis; SpringWorks Therapeutics
Consulting or Advisory Role - AADi; Blueprint Medicines; Daiichi Sankyo; Deciphera; Exelixis; SpringWorks Therapeutics
Research Funding - Deciphera; Eisai; Exelixis; SpringWorks Therapeutics
Travel, Accommodations, Expenses - AADi; Daiichi Sankyo; Deciphera; Exelixis; SpringWorks Therapeutics
 
Jesse Reynolds
No Relationships to Disclose
 
Donald Gehan
No Relationships to Disclose
 
Harold Tara
No Relationships to Disclose
 
Benjamin Newton
No Relationships to Disclose
 
Avanti Verma
No Relationships to Disclose
 
Zafar Sayed
No Relationships to Disclose
 
Ansley Roche
No Relationships to Disclose
 
Saral Mehra
No Relationships to Disclose
 
Benjamin Judson
No Relationships to Disclose
 
Wendell Yarbrough
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - ALX Oncology; Coherus Biosciences; CUE Biopharma; Genentech/Roche; GlaxoSmithKline; IO Biotech; Janssen Oncology; Merck; Merck KGaA; Merus; Mirati Therapeutics; Orphagen Pharmaceuticals; Pfizer; Rakuten Medical; Seagen; Takeda; Vaccinex
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - CUE Biopharma (Inst); Exelixis (Inst); IO Biotech (Inst); Merck; Merck (Inst)
Expert Testimony - Cel-Sci Corporation
Travel, Accommodations, Expenses - Merck; Merck